Veterinary Infusion Pumps Market Size & Share, by Animal Type (Small Animals, Large Animals); Application; End User; Technology; Product Type - Global Supply & Demand Analysis, Growth Forecasts, Statistical Report 2025-2037

Veterinary Infusion Pumps Sector: Growth Drivers and Challenges

Growth Drivers

• Rise in humanization and ownership: According to the 2024 AVMA data report, there has been a surge in pet ownership, accounting for approximately 68% in the U.S., which effectively accelerated veterinary care, thus suitable for the market development. Also, the aspect of veterinary care expenditure has increased by USD 148.5 billion in 2024, with infusion pumps playing a vital role in managing chronic disease among the pet population globally. Besides, clinical upgradation has gained more importance in urban markets, with pet insurance penetration exceeding 38%, thus decreasing cost gaps.

• Increase in rare disease epidemic: Chronic conditions such as cancer, diabetes, and kidney disorder highly require long-term IV therapy solutions, which have increased pump utilization by almost 25% since 2021 and enhanced the market demand worldwide. As per an article published by Banfield in 2024, chronic illness exists in 1 in 4 dogs and 1 in 5 cats, respectively, which has boosted the market requirement effectively. Besides, veterinary infrastructure currently stocks 25% to 35% of pumps in comparison to five years ago, further implementing automated dosing to reduce staff workload.

Veterinary Infusion Pumps Market Historical Patient Growth and Evolution (2014-2024)

There has been a paradigm shift in the global market, effectively driven by an increase in animal healthcare and medical spending, progressive treatment protocols, and a rise in pet ownership. Also, the patient pool aspect for these infusion pumps has increased, especially across the Asia Pacific, Europe, and North America regions, attributed to critical care requirements, surgical interventions, and rare disease management. For instance, the aging pet population in the U.S. comprises approximately 44% of 7-year-old dogs, which has led to a surge in cancer and kidney cases. Based on these aspects, the historical patient growth has positively shaped manufacturer strategies through regulatory harmonization and the presence of market leaders.

2014-2024 Historical Patient Growth (Millions)

The market comprises leading manufacturers, effectively leveraging initiatives such as market-specified pricing, tactical partnerships, and product advancement with the objective of dominating the global market. For instance, B. Braun enhanced its U.S. market share by USD 129.5 billion in the international market. Likewise, Jørgen Kruuse entered into a partnership with veterinary chains in Europe and deployed approximately 5,500 low-cost pumps, and captured 9.2% of the EU market. Besides, developing markets are a key battleground, wherein India is readily making advancement at a 30.2% growth rate, owing to an increase in the demand for infusion pumps in the veterinary field.

Revenue Growth Opportunities for Manufacturers (2024-2030)

Challenges 

• Disruption in the supply chain and tariffs: The aspect of international trade tensions tends to negatively impact the market across different nations. For instance, the trade war between China and the U.S. has resulted in the emergence of 28% tariffs on infusion pump components, which in turn, has deliberately increased overall device costs by 9% to 13%. This further results in supply chain issues, with lead time for microcontrollers increasing to 35 to 65 long days. However, to overcome this, manufacturers have implemented different strategies, for instance, Smiths Medical removed 45% of its sourced components to Mexico from China, and also diminished tariff impacts by almost 18%.

• Presence of cybersecurity risks: The rise in connected devices has unveiled the latest vulnerabilities, which negatively impact the market internationally. For instance, the 2023 Medical Device Cybersecurity Report by the FDA has proclaimed 13 breaches in veterinary infusion pumps, which mainly included alterations in dosage settings by hackers. These hazards are continuously increasing, due to which the average smart pump currently constitutes 16 potential attack vectors, which has increased from 7 in 2020. Besides, the regulatory landscape is equally facing backlash since the EU’s newest Cybersecurity Act imposed a €22 million fine for breaches, thereby causing a hindrance to market upliftment.